Ticarcillinの基礎的・臨床的検討

DOI Web Site

書誌事項

タイトル別名
  • LABORATORY AND CLINICAL STUDIES OF TICARCILLIN
  • Ticarcillin ノ キソテキ リンショウテキ ケントウ

この論文をさがす

抄録

Laboratory and clinical investigations were performed on a new synthetic penicillin, ticarcillin (TIPC), and the following conclusions were obtained.<BR>1. Antibacterial activity of TIPC against 40 strains of Ps. aeruginosa derived from urinary tract, was about 2 times stronger than that of SBPC. Antibacterial activity of CEZ against ABPC resistant E. coil, was superior to that of TIPC, and yet 25% of the strains showed MIC of TIPC ≤ 50μg/ml, while MIC of CEZ≥ 100 μg/ ml.<BR>2. Growth inhibitory effect of TIPC against Ps. aeruginosa, was found in concentration of 1-2MIC, and this remained perfectly for 24 hours.<BR>3. Clinical investigation was made on 40 cases of chronic urinary tract infection. As the results, overall efficacy rate was 38.9% in 18 cases judged on 3rd day, 51.5% in 33 cases judged on 5th day, and 53.8% in 39 cases judged on 7th day. Overall efficacy rate was 50.0% in 22 cases administered a daily dose of 2 g, and 58. 8% in 17 cases administered 3 g. As to the cases under catheterization, efficacy was better at a daily dose of 3 g.<BR>4. As for the side effect, eruption was observed only in 1 case out of all 43 cases treated. As to the laboratory test values, GOT and GPT were elevated slightly only in 1 case.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ